Tag Archives: liver

Doctor with lung cancer gets unprecedented liver, double-lung transplant from Northwestern hospital Chicago – WLS-TV

  1. Doctor with lung cancer gets unprecedented liver, double-lung transplant from Northwestern hospital Chicago WLS-TV
  2. California doctor gets new lungs and liver at Northwestern after damaging treatment for advanced cancer Chicago Sun-Times
  3. Santa Monica doctor doing well after unprecedented liver, double-lung transplant from Northwestern Medicine in Chicago KABC-TV
  4. Breakthrough at Northwestern Medicine: Lung cancer patient has successful lung liver transplant AOL
  5. Northwestern Medicine performs double lung-liver transplant Crain’s Chicago Business

Read original article here

Akero Therapeutics Reports Encouraging 36-Week Analysis of 96-Week Phase 2b SYMMETRY Study, with a Trend on Fibrosis Improvement and Statistically Significant Results for NASH Resolution, Markers of Liver Injury and Fibrosis, Insulin Sensitization an – GlobeNewswire

  1. Akero Therapeutics Reports Encouraging 36-Week Analysis of 96-Week Phase 2b SYMMETRY Study, with a Trend on Fibrosis Improvement and Statistically Significant Results for NASH Resolution, Markers of Liver Injury and Fibrosis, Insulin Sensitization an GlobeNewswire
  2. AKRO Stock Plummets, Dragging Down ETNB Stock, On Liver-Disease Flop Investor’s Business Daily
  3. Stocks trending October 10, 2023: Akero Therapeutics, Palantir, Hyatt Hotels Yahoo Finance
  4. Akero Therapeutics to Present Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis Due to NASH Yahoo Finance
  5. Biggest stock movers today: Coherent, Truist Financial, Akero Therapeutics and more (COHR) Seeking Alpha
  6. View Full Coverage on Google News

Read original article here

Excessive Drinking During the Pandemic Increased Death Rates From Alcoholic Liver Disease — Especially in Humboldt – Lost Coast Outpost

  1. Excessive Drinking During the Pandemic Increased Death Rates From Alcoholic Liver Disease — Especially in Humboldt Lost Coast Outpost
  2. As heavy drinking rose during the COVID-19 pandemic, deaths and hospitalizations for liver disease also jumped, according to WSU research The Spokesman Review
  3. COVID Lockdowns Drove Americans To Drink … At Home … In The Morning, Studies Find The Daily Wire
  4. Excessive drinking, related deaths surged in pandemic Detroit News
  5. The rise of alcohol consumption during the pandemic Wink News
  6. View Full Coverage on Google News

Read original article here

Fatty liver disease was alleviated by Lilly’s ‘triple-G’ obesity drug – STAT

  1. Fatty liver disease was alleviated by Lilly’s ‘triple-G’ obesity drug STAT
  2. A new weight-loss drug dubbed the ‘triple G’ could be stronger than Ozempic, Wegovy, and Mounjaro — and as powerful as bariatric surgery Yahoo Life
  3. Eli Lilly (LLY) Weight-Loss Shot Gives Company’s Strongest Results in Trial Bloomberg
  4. Triple Agonist Retatrutide Hits New Weight-Loss Highs Medscape
  5. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial The Lancet
  6. View Full Coverage on Google News

Read original article here

Doctors Say These are Signs of Congestive Heart Failure, Including Liver Damage — Eat This Not That

Congestive heart failure, also called heart failure, is a serious condition that happens when the heart can’t get enough oxygen and blood to support other organs in the body. It doesn’t mean the heart has stopped beating, but rather it has a hard time pumping much needed nutrients our body requires. “When this happens, blood often backs up and fluid can build up in the lungs, causing shortness of breath,” says the Mayo Clinic. “Certain heart conditions, such as narrowed arteries in the heart (coronary artery disease) or high blood pressure, gradually leave the heart too weak or stiff to fill and pump blood properly.”

Over 6 million Americans have congestive heart failure, according to the Centers for Disease Control and Prevention and “in 2018, heart failure was mentioned on 379,800 death certificates.” John Whyte, MD, MPH, Chief Medical Officer, WebMD tells us, “Congestive Heart failure is quite common,”  It’s the number one reason why people over the age of 65 are hospitalized.  Some people think failure means that all of a sudden the heart stops working like in cardiac arrest.  Heart failure is a process that occurs over several years.”  

The medical community continues to search for improved ways to treat congestive heart failure, but it still remains a common and often fatal health problem. “Congestive heart failure is a domain of active and intensive research in the US and overseas,” Dr. J. Wes Ulm, Harvard and MIT-trained MD, PhD with a background in bioinformatics, gene therapy, genetics, drug discovery, consulting and education explains. “In light of its significant toll and costs – with an estimated prevalence of more than 6 million Americans, and an incidence of close to a million new diagnoses each year – efforts are ongoing to improve its management and to better address its basic physiology, in the form of confronting and reversing the pathological remodeling of heart muscle at the cellular and molecular level. However, CHF is also a classic example of a condition that is usually secondary to other root causes as discussed above. Therefore, the best approach in confronting CHF is to address and prevent the conditions that give it in the first place.”

Read on to learn more about congestive heart failure and signs that indicate you have the condition. As always, please consult your physician for medical advice. 

CHF can have many causes and can be acute or chronic, though in the latter case, it generally involves so-called pathological remodeling. This occurs if the myocardium – the central muscular wall of the heart – undergoes an alteration in its cellular and molecular character which impairs proper function.”

Shutterstock

Dr. Whyte explains, “Congestive Heart Failure can make doing your daily activities much more difficult.  You have less energy.  You have trouble breathing.  That makes it hard to live an active lifestyle.  You retain fluid and that makes you gain weight and that affects how you look and feel.”

Dr. Ulm says, “The specific symptoms will depend on the severity of the CHF, which is essentially categorized as one of four different classes (with patients often moving between them at various times), and on the specific causes and comorbidities, i.e. any other diagnoses that may be present. More broadly, heart failure is classified as being systolic (inadequate heart pumping) or diastolic (inadequate heart filling), with the myocardium essentially becoming too weak in the former and too stiff in the latter. As a rule, CHF by its nature tends to limit daily activity since the heart is unable to supply peripheral tissues with their circulation needs, which is most manifest during periods of heightened exertion.”

Dr. Ulm explains, “CHF generally manifests with fatigue, dyspnea (shortness of breath), elevated heart rate (compensating in part for the insufficient circulatory delivery), and swelling in the feet or legs, sometimes alongside less specific symptoms like confusion, trouble sleeping, or having to awake at night to urinate. There can also be weight gain with fluid retention, heart palpitations, or a dry cough present. The leg and ankle swelling result from a process called edema, in which fluid exits into the tissues beneath the skin, in this case essentially from the backup of circulation when the heart is unable to pump blood adequately into the pulmonary artery (from the right ventricle) and the aorta (from the left ventricle). 

Depending on the stage and severity of the CHF, patients may also have fluid accumulation (ascites) in the abdomen. Upon clinical examination at a doctor’s office, a physician or nurse listening through a stethoscope may hear a crackling sound in the lungs and abnormal sounds from the heart, or may notice cool extremities or a purplish discoloration (cyanosis) from inadequate circulation and oxygenation, depending on CHF severity. An echocardiogram procedure will often note a reduction in the ejection fraction (EF), a hallmark of the inadequate cardiac output that defines the disease.”

Shutterstock

Dr. Whyte says, “There are numerous causes for heart failure.  This includes high blood pressure, kidney disease, and thyroid disease.  If you’ve had a heart attack, that weakens your heart and blood vessels which can cause heart failure. Excess use of alcohol doesn’t just affect the liver — it also affects the heart and that can cause heart failure.” 

According to Dr. Ulm, “Common risk factors for CHF include untreated heart valve disease or congenital cardiac conditions (present at birth or becoming evident later, such as cardiomyopathy), a history of heart attacks or other severe heart disease, poorly controlled hypertension (high blood pressure) or diabetes, and some heart arrhythmias such as inadequately treated atrial fibrillation. Patients with significant obesity or kidney issues, alcoholics, smokers, and recreational drug users are also at increased risk. Some medications can likewise have toxic side effects elevating heart failure risk, and thyrotoxicosis – in which the blood is flooded with excess thyroid hormone, for example from hyperthyroidism or a release after thyroiditis (thyroid inflammation) – can also give rise to CHF. 

There are, furthermore, some rare cases that can be caused by infections such as a severe viral myocarditis, in which the heart muscle itself is infected and inflamed, or a condition known as Chagas disease seen most commonly in Brazil. There is, in addition, mounting concern from recent studies amid the pandemic that some forms of COVID-19 infection may contribute to the risk of myocarditis and heart failure, though research is ongoing for this.”

Shutterstock

Dr. Whyte states, “Complications of congestive heart failure are liver damage, kidney damage, etc. Because heart failure affects how well the heart pumps oxygenated blood to the body, other organs often suffer damage.  In heart failure, the kidneys, liver, and lungs are often damaged. Some people develop sleep apnea when they have heart failure.  Others might experience anemia, or low blood count.” 

Dr. Ulm states, “If left untreated, heart failure can progress to Class IV CHF, in which perfusion from the heart is reduced to the extent that downstream tissues risk injury from inadequate circulation of oxygen and nutrients, and which is associated with elevated morbidity and mortality. In such cases, the pathological remodeling of the heart’s myocardium has advanced to result in significant dysfunction and impaired pumping action. Physical activity is substantially restricted even at rest, and management and recuperation are difficult.”

Shutterstock

Dr. Ulm shares, “Preventive measures for congestive heart failure overlap for the most part with those you’ve probably heard in warding off heart disease in general, for example cessation of smoking and other tobacco use, minimizing alcohol and recreational drugs, partaking in regular exercise, maintaining a healthy body weight, and dietary adjustments to improve fruit and vegetable intake while controlling salt, sugar, and excess saturated fat. It’s important to get regular medical checkups to detect and treat potential issues such as hypertension and, if diagnosed with CHF, to make sure to take the prescribed medications such as diuretics, ACE inhibitors, and beta-blockers. Such regimens essentially help to rest the heart and reduce the burden of adequately perfusing the body, while research suggests they may also help to halt and reverse the pathological remodeling of the myocardium that gives rise to CHF in the first place.

It’s likewise important to keep stress under control and well-managed. This can be easier said than done especially for us in the US; Gallup and other organizations have found that Americans regularly suffer some of the highest stress levels of any developed country. This no doubt also contributes to the relatively higher rates of obesity, substance abuse, and other contributors to CHF that we encounter in the United States, as well as the comparatively dismal life expectancy – among the lowest for advanced nations, even before the COVID pandemic – for which the USA’s significant prevalence of CHF is itself likewise a culprit. But stress management is key to averting CHF and a host of other health issues, which have in many cases been linked to chronic elevation of blood cortisol, a stress hormone produced by the adrenal glands. Deep breathing, yoga, exercise, and broader lifestyle changes are integral to this.”

Wes Ulm, MD, PhD, is a physician-researcher, musician (J. Wes Ulm and Kant’s Konundrum) ,and novelist, and earned a dual MD/PhD degree from Harvard Medical School and MIT. He is part of the Heroes of the COVID Crisis series in relation to his ongoing efforts in the drug discovery and public health arena.

Read original article here

Eating fast food linked to potentially life-threatening liver condition, new study finds

If you needed another reason to kick that late-night fast-food habit, a new eye-opening study on the negative impact of fast food may provide just that. (Alicia Clarke, Alamy)

Estimated read time: 2-3 minutes

TORONTO— If you needed another reason to kick that late-night McDonald’s habit, a new eye-opening study on the negative impact of fast food may provide just that.

A peer-reviewed study from Keck Medicine of USC published in the Clinical Gastroenterology and Hepatology journal has found that consumption of fast food is associated with a potentially life-threatening condition of non-alcoholic fatty liver disorder.

“Our findings are particularly alarming as fast-food consumption has gone up in the last 50 years, regardless of socioeconomic status,” said hepatologist and lead-author on the study Ani Kardashian in a press release.

Those examined in the study who consumed fast food as one-fifth of their daily calories were found to have severely high levels of fat in their liver compared to those who consumed less or none at all.

Even those who consumed a relatively modest amount of fast food can experience harm to the liver, the study found.

The researchers analyzed recent data from the 2017-2018 National Health and Nutrition Examination Survey, the largest annual nutrition survey in the U.S., in order to determine how eating fast food can impact liver steatosis, which is the condition caused by having too much fat build up in your liver.

Fast food was classified as being from either a drive-through restaurant or one without wait staff in the study, including pizza.

The researchers compared the fatty liver measurements of approximately 4,000 adults in the survey to their consumption of fast food, and found that 52% of those evaluated consumed fast food.

Of this group, 29 consumed 20% or more of their daily calories on fast food. This percentage of people were the only ones of the survey to show a rise in liver fat levels.

The prevalence of the fast food and liver steatosis link was true for both the general population and for those with obesity or diabetes, even after data was adjusted for other factors such as age, sex, race, ethnicity, alcohol use and physical activity.

According to Statista, around 29% of Canadian adults 18 years old and above were obese in 2021, and 36% were overweight.

And while there have been other studies linking fast food and obesity, this is the first of its kind to find the impact on liver health, according to Kardashian.

Fat intake should comprise of less than 30% of one’s daily calories and it in order to improve NAFLD, it is essential to consume anti-inflammatory foods rich in mono- and polyunsaturated fatty acids, according to another study.

Foods such as avocados, nuts, and fish are some of the foods high in these beneficial fatty acids.

The researchers hope that these findings encourage health care providers to offer patients more dietary education in the future to those at a higher risk of developing NAFLD from fast food, such as those with obesity or diabetes

Most recent U.S. stories

More stories you may be interested in

Read original article here

Registered Dietitians Share the Very Worst Food For Liver Health

Your liver is important—so take care of it!

There are some parts of the body you likely don’t think about on a regular basis. (When was the last time you wondered how your spleen was doing?) That is, until something goes wrong. The liver is one organ that we often take for granted, but its importance can’t be underestimated.

“The liver produces bile, which is important for fat digestion. It also works to detoxify substances that are foreign to the body and stores fat-soluble vitamins, among other functions,” says Dr. Jinan Banna, PhD, RD, a registered dietitian and associate professor in the Department of Human Nutrition, Food and Animal Sciences at the University of Hawai’i.

Related: Here’s How To Keep Your Liver Healthy

Registered dietitian Lyndsay Hall, RD, emphasizes that the liver is vital. “One of its main roles is to process and metabolize the nutrients, hormones, and substances—such as medication—that pass through our blood in order to maintain balance in our bodies and eliminate potential toxic effects,” she says. Hall adds that the liver also serves as a reserve of energy, otherwise known as glycogen (which is the stored form of glucose) and micronutrients.

Clearly, liver health is key. This is why it’s so concerning that the rise of non-alcoholic fatty liver disease (NAFLD) is on the rise; an estimated 25 percent of people in the U.S. have this chronic liver condition. NAFLD occurs when there is a build-up of fat in liver cells that is not caused by alcohol.

How can you keep your liver healthy? Here, dietitians share the best and worst foods for liver health.

Related: The Very Best Foods for Your Liver, From Summer Berries to Coffee and Green Tea

What Is the Worst Food for Liver Health?

Both Dr. Banna and Hall say that there is one category of food that is truly not good for liver health: ultra-processed foods high in sugar or sodium. This includes things like cookies, chips, sugary breakfast cereals, candy, hot dogs and French fries.

“When we consume sugar in excess, whether it be from refined carbohydrates, like white bread, or candy and our bodies do not require it at that time for energy, we will store whatever sugar is left in the form of fat and this fat can be stored on the liver,” Hall says.

As for foods high in sodium, there is also a strong correlation between diets high in sodium and NAFLD; people with a high-sodium diet are as much as 60 percent more likely to be diagnosed with NAFLD.

Both experts also say that foods high in saturated fat should be minimized, when eating with liver health in mind. Foods high in saturated fat include bacon, sausage, red meat, butter, baked goods, and ice cream. “Some saturated fat is fine in the diet, but saturated fat in excess may lead to accumulation of fat in the liver,” Dr. Banna says.

Hall explains why the reason why foods high in saturated fat should be minimized is that increased intake of saturated fat is often associated with increased blood lipid levels, obesity, and insulin resistance—all of which are conditions that can increase the risk of NAFLD. “The association between the consumption of saturated fat and these health conditions that are known to increase risk of NAFLD is in part due to the creation of damaging ceramides [lipids],” Hall says. “When saturated fat is consumed in excess, it can result in the production of these ceramides, which are fat molecules that can have harmful effects, increasing the risk of conditions like insulin resistance and type 2 diabetes.”

Related: Could This Workout Protect Your Liver from the Effects of Alcohol? Experts Weight In

What To Eat Instead To Support Liver Health

Now that you know what the worst foods for liver health are comes the question of what to eat instead. As you can likely guess, the same foods that are good for other parts of the body, including the brain, heart and gut, support liver health too. “Consuming a balanced diet that is rich in plant-sourced foods is a good way to maintain liver health,” Dr. Banna says.

Not sure where to start? She recommends focusing on fiber, a nutrient that Dr. Banna says the majority of Americans don’t get enough of and is found in foods including fruits, vegetables, and whole grains. Scientific studies have found a strong connection between a high-fiber diet and improving liver health.

Unlike saturated fat, both experts say that unsaturated fat helps support liver health. “Because it is beneficial to limit consumption of saturated fat for the sake of liver health, intake of unsaturated fat becomes increasingly important, as our bodies do require some fat for metabolic processes,” Hall says. Foods with saturated fat include avocado, olive oil, and nuts and seeds.

Hall routinely recommends the Mediterranean diet to clients who are looking for an eating plan that supports liver health. This way of eating emphasizes foods rich in both fiber and unsaturated fat as well as protein sourced primarily from plants and seafood.

It bears repeating that when you eat with liver health in mind, you end up supporting your entire body, including your brain, heart, and gut. If you have already been diagnosed with NAFLD, it’s also important to know that it can be reversed. That’s how powerful dietary and lifestyle habits are. No one has to live with NAFLD. This is one disease that we can control. Pretty empowering, right?

Next up, see a list of 110 foods you can eat while following the Mediterranean diet.

Sources

Read original article here

Worrying signs that your fatty liver is getting worse | Health

Fatty liver often appears harmless and has rarely any symptoms in the initial stages. It all starts with a build-up of fat in liver that is not broken down properly due to consuming too many calories or diseases like diabetes, high cholesterol among others. In the initial stages, there is hardly any inflammation of damage to the liver and many people may not reach advanced stages of fatty liver disease where the risks of liver cirrhosis and liver cancer goes up. Fatty liver in many people goes undiagnosed in the early stages because it’s most asymptomatic. However, as the disease progresses one may start to notice yellowing of skin, dull ache in the lower right side of the ribs, swelling in abdomen, legs, weight loss among many other symptoms. (Also read: 8 fruits you must eat to reverse fatty liver disease)

“Fatty liver is on the rise due to lifestyle and diet changes. A sedentary lifestyle and excess intake of processed and high-calorie diet are some of the major causes of this condition. Though alcohol tops the chart as an etiology for fatty liver, non-alcoholic fatty liver is equally on the rise due to this,” says Dr Amol Dahale, Consultant, Gastroenterology, Manipal Hospitals, Baner-Pune.

“Mostly detected in asymptomatic patients, few people can develop symptoms like upper abdominal pain, nausea, fatigue, decreased appetite even jaundice in a few cases. Though look benign initially, few people develop cirrhosis and even liver cancer which can be fatal,” says Dr Dahale.

Dr. Pratik Tibdewal, Consultant Gastroenterologist, Wockhardt Hospitals, Mira Road explains in detail the four stages of fatty liver disease and when should one start worrying.

FIRST STAGE: NO RED FLAGS

There are four stages of Non-Alcoholic Fatty Liver Disease (NAFLD) which determine the progression of the disease. The first stage is simple fatty liver or steatosis. This happens when the liver cells start to build-up fat, but without inflammation or scarring at this stage. There are no red flags in this stage and a large number of people don’t even know they have fatty liver. Not everyone with fatty liver will get non-alcoholic steatohepatitis (NASH) which is the second stage.

SECOND STAGE: INFLAMMATION

The second stage of NAFLD is non-alcoholic steatohepatitis (NASH). Here, there is a build-up of fat in the liver cells along with inflammation as the liver is repairing damaged tissue. If the damaged tissue is more then there can be scarring of the liver leading to fibrosis

THIRD STAGE: FIBROSIS

The third stage of NAFLD is fibrosis. It is seen when the scar tissue is there in the liver and in the blood vessels around the liver. Thus, treating inflammation may prevent further progression or even reverse some of the damage. However, if not tackled at the right time, it can lead to cirrhosis.

FOURTH STAGE: CIRRHOSIS

The fourth stage of NAFLD is cirrhosis. At this stage, the liver will completely stop working and there can be signs and symptoms such as yellowing of the skin and a dull ache in the lower right side of the ribs and one will suffer from liver damage which can lead to Ascites (abnormal swelling), leg swelling, bleeding from vomiting or altered consciousness which will require hospitalisation and may require a liver transplantation.

Dr Shankar Zanwar Consultant Gastroenterologist, Wockhardt Hospital, Mumbai Central shares fatty liver danger signs that nobody should ignore.

– If the patient starts getting fatigue in activities which are not usually tiresome

– Loss of desire to eat food

– Yellowish discolouration of eyes and urine

– Fullness of abdomen typically due to fluid accumulation

– Blood vomiting

– Black coloured stools

– Leg swelling

– Weight loss

– Abnormal mental activity in form of disturbed sleep and wake cycle, irrelevant talking, disorientation

– Easy bruisability meaning bleeding under skin with trivial injuries

“As the dictum goes that prevention is better than cure, early diagnosis and treatment can lead to a complete reversal of the disease. Today with the availability of multiple detection tools like ultrasound, fibro scan, blood tests, early diagnosis is possible. Regular exercise, dietary and lifestyle changes along with medicines can help us to cure fatty liver,” says Dr Dahale.

Follow more stories on Facebook & Twitter



Read original article here

Off-Patent Liver Disease Drug Could Stop COVID-19 and Protect Against Future Variants

 

Researchers at Cambridge University have found that a previously existing, off-patent medication may be effective in preventing COVID-19 and potentially guarding against future variants of the virus. The discovery was made through a combination of experiments using mini-organs, donor organs, animal studies, and patient data.

Unique experiments involved ‘mini-organs’, animal research, donated human organs, volunteers, and patients.

  • Cambridge scientists have shown that a widely-used drug to treat liver disease can prevent

    Cambridge scientists have identified an off-patent drug that can be repurposed to prevent COVID-19 – and may be capable of protecting against future variants of the virus – in research involving a unique mix of ‘mini-organs’, donor organs, animal studies, and patients.

    The research, published recently in the journal Nature, showed that an existing drug used to treat a type of liver disease is able to ‘lock’ the doorway by which SARS-CoV-2 enters our cells, a receptor on the cell surface known as ACE2. Because this drug targets the host cells and not the virus, it should protect against future new variants of the virus as well as other coronaviruses that might emerge.

    If confirmed in larger clinical trials, this could provide a vital drug for protecting those individuals for whom vaccines are ineffective or inaccessible as well as individuals at increased risk of infection.

    Dr. Fotios Sampaziotis, from the Wellcome-MRC Cambridge Stem Cell Institute at the University of Cambridge and Addenbrooke’s Hospital, led the research in collaboration with Professor Ludovic Vallier from the Berlin Institute of Health at Charité.

    Bile duct/liver organoid infected with SARS-CoV-2 – red indicates the virus. Credit: Teresa Brevini

    Dr. Sampaziotis said: “Vaccines protect us by boosting our immune system so that it can recognize the virus and clear it, or at least weaken it. But vaccines don’t work for everyone – for example patients with a weak immune system – and not everyone has access to them. Also, the virus can mutate into new vaccine-resistant variants.

    “We’re interested in finding alternative ways to protect us from SARS-CoV-2 infection that are not dependent on the immune system and could complement vaccination. We’ve discovered a way to close the door to the virus, preventing it from getting into our cells in the first place and protecting us from infection.”

    From mini-organs and animals…

    Dr. Sampaziotis had previously been working with organoids – ‘mini-bile ducts’ – to study diseases of the bile ducts. Organoids are clusters of cells that can grow and proliferate in culture, taking on a 3D structure that has the same functions as the part of the organ being studied.

    Using these, the researchers found – rather serendipitously – that a molecule known as FXR, which is present in large amounts in these bile duct organoids, directly regulates the viral ‘doorway’ ACE2, effectively opening and closing it. They went on to show that ursodeoxycholic

    Perfused lung. Credit: Teresa Brevini

In this new study, his team showed that they could use the same approach to close the ACE2 doorway in ‘mini-lungs’ and ‘mini-guts’ – representing the two main targets of SARS-CoV-2 – and prevent viral infection.

The next step was to show that the drug could prevent infection not only in lab-grown cells but also in living organisms. For this, they teamed up with Professor Andrew Owen from the University of Liverpool to show that the drug prevented infection in hamsters exposed to the virus, which are used as the ‘gold-standard’ model for pre-clinical testing of drugs against SARS-CoV-2. Importantly, the hamsters treated with UDCA were protected from the delta variant of the virus, which was new at the time and was partially resistant to existing vaccines.

Professor Owen said: “Although we will need properly-controlled randomized trials to confirm these findings, the data provide compelling evidence that UDCA could work as a drug to protect against COVID-19 and complement vaccination programs, particularly in vulnerable population groups. As it targets the ACE2 receptor directly, we hope it may be more resilient to changes resulting from the evolution of the SARS-CoV-2 spike, which result in the rapid emergence of new variants.”

… to human organs…

Next, the researchers worked with Professor Andrew Fisher from Newcastle University and Professor Chris Watson from Addenbrooke’s hospital to see if their findings in hamsters held true in human lungs exposed to the virus.

The team took a pair of donated lungs not suitable for transplantation, keeping them breathing outside the body with a ventilator and using a pump to circulate blood-like fluid through them to keep the organs functioning while they could be studied. One lung was given the drug, but both were exposed to SARS-CoV-2. Sure enough, the lung that received the drug did not become infected, while the other lung did.

Professor Fisher said: “This is one of the first studies to test the effect of a drug in a whole human organ while it’s being perfused. This could prove important for organ transplantation – given the risks of passing on COVID-19 through transplanted organs, it could open up the possibility of treating organs with drugs to clear the virus before transplantation.”

… to people

Moving next to human volunteers, the Cambridge team collaborated with Professor Ansgar Lohse from the University Medical Centre Hamburg-Eppendorf in Germany.

Professor Lohse explained: “We recruited eight healthy volunteers to receive the drug. When we swabbed the noses of these volunteers, we found lower levels of ACE2, suggesting that the virus would have fewer opportunities to break into and infect their nasal cells – the main gateway for the virus.”

While it wasn’t possible to run a full-scale clinical trial, the researchers did the next best thing: looking at data on COVID-19 outcomes from two independent cohorts of patients, comparing those individuals who were already taking UDCA for their liver conditions against patients not receiving the drug. They found that patients receiving UDCA were less likely to develop severe COVID-19 and be hospitalized.

A safe, affordable variant-proof drug

First author and PhD candidate Teresa Brevini from the University of Cambridge said: “This unique study gave us the opportunity to do really translational science, using a laboratory finding to directly address a clinical need.

“Using almost every approach at our fingertips we showed that an existing drug shuts the door on the virus and can protect us from COVID-19. Importantly, because this drug works on our cells, it is not affected by mutations in the virus and should be effective even as new variants emerge.”

Dr. Sampaziotis said the drug could be an affordable and effective way of protecting those for whom the COVID-19 vaccine is ineffective or inaccessible. “We have used UDCA in clinic for many years, so we know it’s safe and very well tolerated, which makes administering it to individuals with high COVID-19 risk straightforward.

“This tablet costs little, can be produced in large quantities fast and easily stored or shipped, which makes it easy to rapidly deploy during outbreaks – especially against vaccine-resistant variants, when it might be the only line of protection while waiting for new vaccines to be developed. We are optimistic that this drug could become an important weapon in our fight against COVID-19.”

Reference: “FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2” by Teresa Brevini, Mailis Maes, Gwilym J. Webb, Binu V. John, Claudia D. Fuchs, Gustav Buescher, Lu Wang, Chelsea Griffiths, Marnie L. Brown, William E. Scott III, Pehuén Pereyra-Gerber, William T. H. Gelson, Stephanie Brown, Scott Dillon, Daniele Muraro, Jo Sharp, Megan Neary, Helen Box, Lee Tatham, James Stewart, Paul Curley, Henry Pertinez, Sally Forrest, Petra Mlcochova, Sagar S. Varankar, Mahnaz Darvish-Damavandi, Victoria L. Mulcahy, Rhoda E. Kuc, Thomas L. Williams, James A. Heslop, Davide Rossetti, Olivia C. Tysoe, Vasileios Galanakis, Marta Vila-Gonzalez, Thomas W. M. Crozier, Johannes Bargehr, Sanjay Sinha, Sara S. Upponi, Corrina Fear, Lisa Swift, Kourosh Saeb-Parsy, Susan E. Davies, Axel Wester, Hannes Hagström, Espen Melum, Darran Clements, Peter Humphreys, Jo Herriott, Edyta Kijak, Helen Cox, Chloe Bramwell, Anthony Valentijn, Christopher J. R. Illingworth, UK-PBC research consortium, Bassam Dahman, Dustin R. Bastaich, Raphaella D. Ferreira, Thomas Marjot, Eleanor Barnes, Andrew M. Moon, Alfred S. Barritt IV, Ravindra K. Gupta, Stephen Baker, Anthony P. Davenport, Gareth Corbett, Vassilis G. Gorgoulis, Simon J. A. Buczacki, Joo-Hyeon Lee, Nicholas J. Matheson, Michael Trauner, Andrew J. Fisher, Paul Gibbs, Andrew J. Butler, Christopher J. E. Watson, George F. Mells, Gordon Dougan, Andrew Owen, Ansgar W. Lohse, Ludovic Vallier and Fotios Sampaziotis, 5 December 2022, Nature.
DOI: 10.1038/s41586-022-05594-0

The research was largely funded by UK Research & Innovation, the European Association for the Study of the Liver, the NIHR Cambridge Biomedical Research Centre and the Evelyn Trust.



Read original article here